Home / Manufacturers / ANI # Explanation: Metoclopramide hydrochloride is a gastrointestinal medication originally developed by A.H. Robins (later acquired by Wyeth/Pfizer). The current rights to the brand-name version, **Reglan** (the reference listed drug for the tablet form), are held in the United States by **ANI Pharmaceuticals**. While other companies like Hikma hold the rights to the injectable form and various manufacturers produce generic versions, ANI is the primary owner of the oral brand rights. Following the instruction to provide only the core company name and remove suffixes like "Pharmaceuticals" or "Inc", the result is **ANI**.

ANI # Explanation: Metoclopramide hydrochloride is a gastrointestinal medication originally developed by A.H. Robins (later acquired by Wyeth/Pfizer). The current rights to the brand-name version, Reglan (the reference listed drug for the tablet form), are held in the United States by ANI Pharmaceuticals. While other companies like Hikma hold the rights to the injectable form and various manufacturers produce generic versions, ANI is the primary owner of the oral brand rights. Following the instruction to provide only the core company name and remove suffixes like "Pharmaceuticals" or "Inc", the result is ANI.

Under review·Mar 12, 2026

Drugs from ANI # Explanation: Metoclopramide hydrochloride is a gastrointestinal medication originally developed by A.H. Robins (later acquired by Wyeth/Pfizer). The current rights to the brand-name version, Reglan (the reference listed drug for the tablet form), are held in the United States by ANI Pharmaceuticals. While other companies like Hikma hold the rights to the injectable form and various manufacturers produce generic versions, ANI is the primary owner of the oral brand rights. Following the instruction to provide only the core company name and remove suffixes like "Pharmaceuticals" or "Inc", the result is ANI. (1)

METOCLOPRAMIDE hydrochloride
Metoclopramide Hydrochloride